Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1. (Q38745611)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 September 2016

Language	Label	Description	Also known as
English	Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1.	scientific article published on 19 September 2016

Statements

scholarly article

1 reference

Europe PubMed Central

6 September 2017

Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1. (English)

1 reference

Europe PubMed Central

6 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

tumor angiogenesis

1 reference

based on heuristic

inferred from title

Mohit Hulsurkar

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27641328%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Z Li

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27641328%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Y Zhang

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27641328%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

X Li

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27641328%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

D Zheng

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27641328%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

W Li

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27641328%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

0 references

publication date

19 September 2016

1 reference

Europe PubMed Central

6 September 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27641328%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27641328%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27641328%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1525-1536

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27641328%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

https://scigraph.springernature.com/pub.10.1038/onc.2016.319

0 references

Effects of psychological and social factors on organic disease: a critical assessment of research on coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Depression and Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

The influence of bio-behavioural factors on tumour biology: pathways and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Beta blockers and breast cancer mortality: a population- based study

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Neuroendocrine influences on cancer progression.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Nuclear protein CBP is a coactivator for the transcription factor CREB

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Recruitment of cAMP-response element-binding protein and histone deacetylase has opposite effects on glucocorticoid receptor gene transcription

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

The language of covalent histone modifications

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Deacetylase activity is required for cAMP activation of a subset of CREB target genes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

VEGF and the quest for tumour angiogenesis factors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

The hemostatic system and angiogenesis in malignancy.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Quantitative assessment of angiogenesis, perfused blood vessels and endothelial tip cells in the postnatal mouse brain.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Angiogenesis assays: a critical overview

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Current methods for assaying angiogenesis in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

The Molecular Taxonomy of Primary Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Integrative clinical genomics of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Characterization of a CREB gain-of-function mutant with constitutive transcriptional activity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

The mechanism of CD47-dependent killing of T cells: heterotrimeric Gi-dependent inhibition of protein kinase A.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

New and emerging HDAC inhibitors for cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

GRK3 is essential for metastatic cells and promotes prostate tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

21 January 2018

Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

31 March 2020

In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

31 March 2020

GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.319

31 March 2020

β-Adrenergic Receptor Signaling in Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27641328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/27641328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Behavioral stress accelerates prostate cancer development in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/27641328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38745611&oldid=1559837200"